<scp>MicroRNA</scp>‐181 in cardiovascular disease: Emerging biomarkers and therapeutic targets-Reference-Cited by-同舟云学术

MicroRNA‐181 in cardiovascular disease: Emerging biomarkers and therapeutic targets

Published:2024-05 Issue:9 Volume:38 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Lv Bingjie¹²³^ORCID,He Shaolin¹²³^ORCID,Li Peixin⁴^ORCID,Jiang Shijiu¹²³⁵^ORCID,Li Dazhu¹²³^ORCID,Lin Jibin¹²³^ORCID,Feinberg Mark W.⁶^ORCID

Affiliation:

1. Department of Cardiology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

3. Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

4. Second Clinical School, Tongji Medical College Huazhong University of Science and Technology Wuhan China

5. Department of Cardiology, The First Affiliated Hospital Shihezi University Shihezi China

6. Department of Medicine, Cardiovascular Division Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA

Abstract

AbstractCardiovascular disease (CVD) is the leading cause of death worldwide. MicroRNAs (MiRNAs) have attracted considerable attention for their roles in several cardiovascular disease states, including both the physiological and pathological processes. In this review, we will briefly describe microRNA‐181 (miR‐181) transcription and regulation and summarize recent findings on the roles of miR‐181 family members as biomarkers or therapeutic targets in different cardiovascular‐related conditions, including atherosclerosis, myocardial infarction, hypertension, and heart failure. Lessons learned from these studies may provide new theoretical foundations for CVD.

Funder

National Natural Science Foundation of China

Foundation for the National Institutes of Health

American Heart Association

Publisher

Wiley

Reference86 articles.

1. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

2. microRNAs in action: biogenesis, function and regulation

3. MicroRNAs in Cardiovascular Disease

4. Role of miR-181 family in regulating vascular inflammation and immunity

5. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the Beat: Understanding Inherited Risk and Therapeutic Opportunities in Cardiovascular Diseases with Emphasis on Inherited Cardiomyopathies and Inherited Arrhythmic Syndromes;Cardiogenetics;2024-09-02

2. Systemic delivery of murine SOD2 mRNA to experimental abdominal aortic aneurysm mitigates expansion and rupture;2024-06-18